These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 22526297)

  • 21. Soluble epoxide hydrolase inhibition improves coronary endothelial function and prevents the development of cardiac alterations in obese insulin-resistant mice.
    Roche C; Besnier M; Cassel R; Harouki N; Coquerel D; Guerrot D; Nicol L; Loizon E; Remy-Jouet I; Morisseau C; Mulder P; Ouvrard-Pascaud A; Madec AM; Richard V; Bellien J
    Am J Physiol Heart Circ Physiol; 2015 May; 308(9):H1020-9. PubMed ID: 25724490
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Podocyte-specific soluble epoxide hydrolase deficiency in mice attenuates acute kidney injury.
    Bettaieb A; Koike S; Chahed S; Zhao Y; Bachaalany S; Hashoush N; Graham J; Fatima H; Havel PJ; Gruzdev A; Zeldin DC; Hammock BD; Haj FG
    FEBS J; 2017 Jul; 284(13):1970-1986. PubMed ID: 28485854
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute arsenic toxicity alters cytochrome P450 and soluble epoxide hydrolase and their associated arachidonic acid metabolism in C57Bl/6 mouse heart.
    Anwar-Mohamed A; El-Sherbeni AA; Kim SH; Althurwi HN; Zordoky BN; El-Kadi AO
    Xenobiotica; 2012 Dec; 42(12):1235-47. PubMed ID: 22680237
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Soluble epoxide hydrolase inhibitor promotes immunomodulation to inhibit bone resorption.
    Napimoga MH; Rocha EP; Trindade-da-Silva CA; Demasi APD; Martinez EF; Macedo CG; Abdalla HB; Bettaieb A; Haj FG; Clemente-Napimoga JT; Inceoglu B; Hammock BD
    J Periodontal Res; 2018 Oct; 53(5):743-749. PubMed ID: 29851077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological Inhibition of Soluble Epoxide Hydrolase Ameliorates Chronic Ethanol-Induced Cardiac Fibrosis by Restoring Autophagic Flux.
    Zhou C; Huang J; Li Q; Zhan C; He Y; Liu J; Wen Z; Wang DW
    Alcohol Clin Exp Res; 2018 Oct; 42(10):1970-1978. PubMed ID: 30047995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of soluble epoxide hydrolase attenuates a high-fat diet-mediated renal injury by activating PAX2 and AMPK.
    Luo Y; Wu MY; Deng BQ; Huang J; Hwang SH; Li MY; Zhou CY; Zhang QY; Yu HB; Zhao DK; Zhang G; Qin L; Peng A; Hammock BD; Liu JY
    Proc Natl Acad Sci U S A; 2019 Mar; 116(11):5154-5159. PubMed ID: 30804206
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of soluble epoxide hydrolase enhances the anti-inflammatory effects of aspirin and 5-lipoxygenase activation protein inhibitor in a murine model.
    Liu JY; Yang J; Inceoglu B; Qiu H; Ulu A; Hwang SH; Chiamvimonvat N; Hammock BD
    Biochem Pharmacol; 2010 Mar; 79(6):880-7. PubMed ID: 19896470
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Soluble epoxide hydrolase inhibition and gene deletion are protective against myocardial ischemia-reperfusion injury in vivo.
    Motoki A; Merkel MJ; Packwood WH; Cao Z; Liu L; Iliff J; Alkayed NJ; Van Winkle DM
    Am J Physiol Heart Circ Physiol; 2008 Nov; 295(5):H2128-34. PubMed ID: 18835921
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The flavonoid luteolin inhibits niacin-induced flush.
    Papaliodis D; Boucher W; Kempuraj D; Theoharides TC
    Br J Pharmacol; 2008 Apr; 153(7):1382-7. PubMed ID: 18223672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Soluble epoxide hydrolase gene deletion is protective against experimental cerebral ischemia.
    Zhang W; Otsuka T; Sugo N; Ardeshiri A; Alhadid YK; Iliff JJ; DeBarber AE; Koop DR; Alkayed NJ
    Stroke; 2008 Jul; 39(7):2073-8. PubMed ID: 18369166
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of Soluble Epoxide Hydrolase Attenuates Bosutinib-Induced Blood Pressure Elevation.
    Cui Z; Li B; Zhang Y; He J; Shi X; Wang H; Zhao Y; Yao L; Ai D; Zhang X; Zhu Y
    Hypertension; 2021 Nov; 78(5):1527-1540. PubMed ID: 34601968
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Soluble epoxide hydrolase deficiency or inhibition enhances murine hypoxic pulmonary vasoconstriction after lipopolysaccharide challenge.
    Wepler M; Beloiartsev A; Buswell MD; Panigrahy D; Malhotra R; Buys ES; Radermacher P; Ichinose F; Bloch DB; Zapol WM
    Am J Physiol Lung Cell Mol Physiol; 2016 Dec; 311(6):L1213-L1221. PubMed ID: 27815261
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of sEH via stabilizing the level of EETs alleviated Alzheimer's disease through GSK3β signaling pathway.
    Sun CP; Zhang XY; Zhou JJ; Huo XK; Yu ZL; Morisseau C; Hammock BD; Ma XC
    Food Chem Toxicol; 2021 Oct; 156():112516. PubMed ID: 34411643
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Soluble epoxide hydrolase contamination of specific catalase preparations inhibits epoxyeicosatrienoic acid vasodilation of rat renal arterioles.
    Gauthier KM; Olson L; Harder A; Isbell M; Imig JD; Gutterman DD; Falck JR; Campbell WB
    Am J Physiol Renal Physiol; 2011 Oct; 301(4):F765-72. PubMed ID: 21753077
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics and in vivo potency of soluble epoxide hydrolase inhibitors in cynomolgus monkeys.
    Ulu A; Appt S; Morisseau C; Hwang SH; Jones PD; Rose TE; Dong H; Lango J; Yang J; Tsai HJ; Miyabe C; Fortenbach C; Adams MR; Hammock BD
    Br J Pharmacol; 2012 Mar; 165(5):1401-12. PubMed ID: 21880036
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tetramethylpyrazine suppresses angiotensin II-induced soluble epoxide hydrolase expression in coronary endothelium via anti-ER stress mechanism.
    Mak SK; Yu CM; Sun WT; He GW; Liu XC; Yang Q
    Toxicol Appl Pharmacol; 2017 Dec; 336():84-93. PubMed ID: 29066182
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Soluble epoxide hydrolase inhibitor attenuates BBB disruption and neuroinflammation after intracerebral hemorrhage in mice.
    Tian Y; Yuan X; Wang Y; Wu Q; Fang Y; Zhu Z; Song G; Xu L; Wang W; Xie M
    Neurochem Int; 2021 Nov; 150():105197. PubMed ID: 34592333
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Soluble epoxide hydrolase activation by S-nitrosation contributes to cardiac ischemia-reperfusion injury.
    Ding Y; Li Y; Zhang X; He J; Lu D; Fang X; Wang Y; Wang J; Zhang Y; Qiao X; Gan LM; Chen C; Zhu Y
    J Mol Cell Cardiol; 2017 Sep; 110():70-79. PubMed ID: 28736260
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vascular Endothelial Over-Expression of Human Soluble Epoxide Hydrolase (Tie2-sEH Tr) Attenuates Coronary Reactive Hyperemia in Mice: Role of Oxylipins and ω-Hydroxylases.
    Hanif A; Edin ML; Zeldin DC; Morisseau C; Falck JR; Nayeem MA
    PLoS One; 2017; 12(1):e0169584. PubMed ID: 28056085
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Soluble Epoxide Hydrolase Pharmacological Inhibition Ameliorates Experimental Acute Pancreatitis in Mice.
    Bettaieb A; Chahed S; Bachaalany S; Griffey S; Hammock BD; Haj FG
    Mol Pharmacol; 2015 Aug; 88(2):281-90. PubMed ID: 25993999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.